Simon Moroney, D.Phil.

• Co-Founder and CEO of MorphoSys AG from 1992–2019

• Helped establish MorphoSys as a leader in therapeutic antibodies with one of the industry’s broadest drug candidate pipelines

• Vice-Chair of Novartis Board of Directors; Board member since 2020

• Board Chair of Biotalys NV

• Doctorate in chemistry from the University of Oxford; Master’s degree
  in chemistry from the University of Waikato